R-Pag 12.5 Tablet Tablet

About R-Pag 12.5 Tablet

R-Pag 12.5 Tablet comes as a tablet with 12.5 mg of Eltrombopag, from Renata PLC. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

There are 7 brands of Eltrombopag listed in Bangladesh.

What is R-Pag 12.5 Tablet?

The tablet R-Pag 12.5 Tablet contains Eltrombopag and is made by Renata PLC. For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Ask your doctor or pharmacist if you are unsure about it.

Uses of R-Pag 12.5 Tablet

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Your doctor will decide if it is suitable for you.

How to use R-Pag 12.5 Tablet

Swallow the tablet with water. R-Pag 12.5 Tablet is taken by mouth. Take R-Pag 12.5 Tablet 12.5 mg tablet by mouth as your doctor tells you. Do not change the dose or stop early without asking your doctor. Complete the course exactly as prescribed.

Side effects of R-Pag 12.5 Tablet

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity. Ask your doctor first if any of these apply to you.

Frequently asked questions

What is R-Pag 12.5 Tablet used for?

For the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy. For the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.

How should I take R-Pag 12.5 Tablet?

Swallow the tablet with water. R-Pag 12.5 Tablet is taken by mouth.

What should I watch for while using R-Pag 12.5 Tablet?

He following clinically significant adverse reactions associated with Eltrombopag are described in other sections. Tell your doctor if any side effect bothers you or does not go away.

Is R-Pag 12.5 Tablet safe for everyone?

The estimated background risk of major birth defects and miscarriage for the indicated population is unknown. Eltrombopag may increase the risk of severe and potentially life-threatening hepatotoxicity.

Alternative brands of Eltrombopag

Other brands with the same generic name, cheapest first.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.